Choice of Management of Southern Chinese BRCA Mutation Carriers
Authors:
- 25 February 2010
- journal article
- research article
- Published by Wiley in World Journal of Surgery
- Vol. 34 (7) , 1416-1426
Abstract
Background: Mutations in the BRCA genes confer greater risk of developing breast, ovarian, and prostate cancer. Families carrying the mutation can have intensive surveillance and take preventative measures. This is the first report on the uptake of such interventions in Chinese mutation carriers residing in Asia.Methods: Breast and ovarian cancer index patients and family members referred for genetic counselling and testing who are found to carry the BRCA mutations were included in this multicenter study.Results: A total of 31 patients with breast and/or ovarian cancer were found to carry BRCA1 or BRCA2 mutations. Forty‐one tested family members also carried the mutations. Of the females, 85.7% of the index patients opted for breast surveillance and 23.8% for prophylactic mastectomy. Of the family members, 82.4% chose breast surveillance and 17.7% had prophylactic mastectomy. The majority of index patients and family members preferred ovarian surveillance (84 and 82.4%). Amongst the index patients, 32% decided for prophylactic salpingo‐oophorectomy; 17.6% of the family members who did not have history of ovarian cancer decided to have prophylactic salpingo‐oophorectomy. All male index patients agreed to breast and prostate surveillance, including breast clinical examination and PSA monitoring. For those male family members found to be BRCA mutation carriers, 56.3% agreed to have breast surveillance and 66.7% agreed to have prostate surveillance. No index patient or family member agreed to any form of chemoprevention.Conclusions: Chinese BRCA mutation carriers have a higher uptake of cancer surveillance than prophylactic surgery and have a lack of interest in the use of chemoprevention drugs.Keywords
Funding Information
- Hong Kong Cancer Fund
This publication has 86 references indexed in Scilit:
- Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutationCancer, 2009
- Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patientsBreast Cancer Research and Treatment, 2008
- Unilateral and Bilateral Breast Cancer in Women Surviving Pediatric Hodgkin's DiseaseInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriersInternational Journal of Cancer, 2008
- Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery firstRadiotherapy and Oncology, 2007
- Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-upBritish Journal of Cancer, 2007
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Science, 2003
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesThe American Journal of Human Genetics, 1998
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997